Uri Weinberg

Novocure GmbH, Lucerne, Switzerland

Affiliated withNovocure GmbH, Lucerne, Switzerland

Research Area

Cancer Research

Biography

Uri Weinberg has not added Biography.
If you are Uri Weinberg and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 57	2017

Other Publications

Article	Year
[Pandora's box of anatomy]. Harefuah\| PubMed ID: 18770971	2008
Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19995900	2010
Tumor treating fields: concept, evidence and future. Expert opinion on investigational drugs\| PubMed ID: 21548832	2011
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 22608262	2012
Tumor treating fields: a new frontier in cancer therapy. Annals of the New York Academy of Sciences\| PubMed ID: 23659608	2013
Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]\| PubMed ID: 24555979	2014
Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo. Seminars in oncology\| PubMed ID: 25213867	2014
NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study. World journal of surgical oncology\| PubMed ID: 26558989	2015
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells. Scientific reports\| PubMed ID: 26658786	2015
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA\| PubMed ID: 26670971	2015
Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo. International journal of cancer\| PubMed ID: 27561100	2016
First steps to creating a platform for high throughput simulation of TTFields. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference\| PubMed ID: 28268799	2016
Using computational phantoms to improve delivery of Tumor Treating Fields (TTFields) to patients. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference\| PubMed ID: 28269726	2016